Erika L. Eves
2021
In 2021, Erika L. Eves earned a total compensation of $236.7K as Vice President, Finance & Administration at Navidea Biopharmaceuticals, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $29,614 |
|---|---|
| Option Awards | $23,481 |
| Salary | $171,072 |
| Other | $12,563 |
| Total | $236,730 |
Eves received $171.1K in salary, accounting for 72% of the total pay in 2021.
Eves also received $29.6K in non-equity incentive plan, $23.5K in option awards and $12.6K in other compensation.
Rankings
In 2021, Erika L. Eves' compensation ranked 11,845th out of 12,397 executives tracked by ExecPay. In other words, Eves earned more than 4.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,845 out of 12,397 | 5th |
Division Manufacturing | 5,228 out of 5,492 | 5th |
Major group Chemicals And Allied Products | 2,285 out of 2,367 | 4th |
Industry group Drugs | 2,027 out of 2,090 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 58 out of 61 | 5th |
Source: SEC filing on October 24, 2022.
Eves' colleagues
We found four more compensation records of executives who worked with Erika L. Eves at Navidea Biopharmaceuticals in 2021.